Study: Hypercholesterolemia patients adherent to medication regimen may be healthier, but at a price

ST. PAUL, Minn. — Patients with high cholesterol who take statins may be healthier than those who do not, but their overall healthcare costs may be slightly higher than their counterparts, according to a new study.

The study, conducted by pharmacy benefit manager Prime Therapeutics in collaboration with Blue Cross and Blue Shield of Minnesota, found that while hypercholesterolemia patients adherent to statin medication went to the hospital or emergency department 2.6% less often than nonadherent individuals — resulting in medical costs that were 7% lower (a difference of $767) — the lower medical costs were offset by pharmacy costs that were 45% higher (a difference of $1,606). In the study, researchers from Prime and Blue Cross compared medical and pharmacy costs among individuals with high cholesterol who were adherent to their statin medication to individuals who were not adherent ("adherence" was defined as following the medication regime 80% of the time or more). Of the 45,869 members included in the study, 21,693 (47.3%) were adherent and 24,176 (52.7%) nonadherent during the two-year follow-up period.

The study results were presented at the Academy of Managed Care Pharmacy's 2012 Educational Conference.

"This study is a continuation of our collaborative work with Blue Cross into understanding the connection between adherence and total cost of health care, including hospitalizations," said Pat Gleason, director of clinical outcomes assessment with Prime. "With the increasing availability of generic statins, especially the generic atorvastatin of the brand Lipitor, the higher pharmacy costs we found may be lowered. In this study, adherence to statins was associated with lower medical costs and hospitalizations, two very important outcomes that will help up us recommend solutions that lead to healthier outcomes for individuals."

To view the full results of the study, click here.

Interested in this topic? Sign up for our weekly Collaborative Care e-newsletter.


- 3:23 PM
Ross says

A LARGE study should also be conducted to look at the symptoms from taking Satins long term. The worse thus far is memory loss. A great many patients also suffer from muscle and joint pain with little knowledge as to the why and most physicians want their patients to continue on with the stains because of the industry profits as opposed to the "good" test results. A better understanding of the true, long and short term effects of these drugs needs to be investigated. I doubt unfortunately this will happen for the reason stated above and that is a medical shame. There are small studies out there, yet the public is not informed. Sometimes, bigger is better...

- 1:40 PM
Hugh says

I'm not surprised by the study results, I would have been surprised if those who stick to their treatments were in worse health that the others. When it comes to such devastating conditions I think it's essential to for the patients to be adherent to their treatment.

Login or Register to post a comment.